
Emily Slotkin MD
Pediatric Sarcoma Oncology
Physician
1275 York AvenueNew York, NY 10065
Overview of Dr. Slotkin
Dr. Emily Slotkin is a pediatric hematologist and oncologist based in New York, NY, with subspecialty in pediatric sarcoma oncology. She completed her residency in Pediatrics at the Jacobi Medical Center/Albert Einstein College of Medicine and further pursued her Fellowship in Pediatric Hematology/Oncology at New York Presbyterian Hospital (Cornell Campus). She is known for her numerous publications in respected journals such as Cancer Research, European Journal of Cancer, and Clinical Cancer Research, some of which have been cited by other publications. Dr. Slotkin is involved in several clinical trials as a contact or principal investigator, including studies involving patients with solid tumors and Ewing sarcoma among others.
Education & Training
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 2008 - 2011
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2008
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 2011 - 2028
NJ State Medical License 2024 - 2027
American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Expanded Access Use of L-MTP-PE for the Treatment of Osteosarcoma
- Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor Start of enrollment: 2020 Dec 22
- A Study of LY2880070 and Gemcitabine in People With Ewing Sarcoma,Ewing-Like Sarcoma, and Desmoplastic Small Round Cell Tumor Start of enrollment: 2022 Mar 02
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies.Filemon S Dela Cruz, Daoqi You, Tamar Y Feinberg, Samantha Brosius, Xinyi Wang
Cancer Research. 2026-07-02 - Does Longitudinal Targeted Panel Sequencing Provide Clinically Relevant Information in Translocation-Associated Sarcomas?Mohamed A Yakoub, Carla Saoud, Damon R Reed, Leonard Wexler, Emily Slotkin
JCO Precision Oncology. 2026-04-01 - Osteosarcoma is not a single disease: Considerations for multidisciplinary management of jaw (gnathic) osteosarcoma.Damon R Reed, Emily K Slotkin
Cancer. 2026-03-15
Press Mentions
- Drug Combination Shows Promise for Rhabdomyosarcoma, but Can It Get to Clinical Trials?December 9th, 2022
MSK Research Highlights, April 27, 2026April 28th, 2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









